Bio-Rad Laboratories Inc (BIO)
301.53
+0.56
(+0.19%)
USD |
NYSE |
May 16, 13:13
Bio-Rad Laboratories Shareholders Equity (Quarterly): 9.051B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.051B |
December 31, 2023 | 8.741B |
September 30, 2023 | 8.416B |
June 30, 2023 | 8.447B |
March 31, 2023 | 9.764B |
December 31, 2022 | 9.615B |
September 30, 2022 | 8.454B |
June 30, 2022 | 8.923B |
March 31, 2022 | 10.18B |
December 31, 2021 | 13.69B |
September 30, 2021 | 15.33B |
June 30, 2021 | 11.59B |
March 31, 2021 | 10.61B |
December 31, 2020 | 9.880B |
September 30, 2020 | 8.825B |
June 30, 2020 | 7.353B |
March 31, 2020 | 6.293B |
December 31, 2019 | 5.755B |
September 30, 2019 | 5.131B |
June 30, 2019 | 5.487B |
March 31, 2019 | 4.864B |
December 31, 2018 | 4.020B |
September 30, 2018 | 4.900B |
June 30, 2018 | 4.639B |
March 31, 2018 | 4.488B |
Date | Value |
---|---|
December 31, 2017 | 2.930B |
September 30, 2017 | 2.848B |
June 30, 2017 | 2.811B |
March 31, 2017 | 2.707B |
December 31, 2016 | 2.579B |
September 30, 2016 | 2.703B |
June 30, 2016 | 2.615B |
March 31, 2016 | 2.544B |
December 31, 2015 | 2.491B |
September 30, 2015 | 2.430B |
June 30, 2015 | 2.359B |
March 31, 2015 | 2.199B |
December 31, 2014 | 2.185B |
September 30, 2014 | 2.177B |
June 30, 2014 | 2.250B |
March 31, 2014 | 2.233B |
December 31, 2013 | 2.187B |
September 30, 2013 | 2.124B |
June 30, 2013 | 2.071B |
March 31, 2013 | 2.031B |
December 31, 2012 | 2.015B |
September 30, 2012 | 1.935B |
June 30, 2012 | 1.852B |
March 31, 2012 | 1.840B |
December 31, 2011 | 1.744B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.131B
Minimum
Sep 2019
15.33B
Maximum
Sep 2021
9.077B
Average
8.874B
Median
Shareholders Equity (Quarterly) Benchmarks
Agilent Technologies Inc | 6.188B |
Bruker Corp | 1.415B |
Azenta Inc | 2.223B |
Harvard Bioscience Inc | 68.81M |
Bionano Genomics Inc | 82.77M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.61B |
Total Liabilities (Quarterly) | 3.559B |
Debt to Equity Ratio | 0.1315 |
Current Ratio | 6.566 |
Net Debt Paydown Yield | 0.02% |